A detailed history of Rothschild Investment LLC transactions in Dyne Therapeutics, Inc. stock. As of the latest transaction made, Rothschild Investment LLC holds 90 shares of DYN stock, worth $2,634. This represents 0.0% of its overall portfolio holdings.

Number of Shares
90
Previous 35 157.14%
Holding current value
$2,634
Previous $1.24 Million 161.78%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

BUY
$31.94 - $47.04 $1,756 - $2,587
55 Added 157.14%
90 $3.23 Million
Q2 2024

Jul 30, 2024

BUY
$23.65 - $35.63 $827 - $1,247
35 New
35 $1.24 Million
Q1 2024

Jul 31, 2024

SELL
$13.06 - $29.18 $391 - $875
-30 Reduced 85.71%
5 $142,000

Others Institutions Holding DYN

About Dyne Therapeutics, Inc.


  • Ticker DYN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 51,765,400
  • Market Cap $1.52B
  • Description
  • Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...
More about DYN
Track This Portfolio

Track Rothschild Investment LLC Portfolio

Follow Rothschild Investment LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rothschild Investment LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rothschild Investment LLC with notifications on news.